nodes	percent_of_prediction	percent_of_DWPC	metapath
Clenbuterol—TNF—gestational diabetes	0.99	1	CbGaD
Clenbuterol—TNF—Transcription factor regulation in adipogenesis—ADIPOQ—gestational diabetes	0.00064	0.0639	CbGpPWpGaD
Clenbuterol—TNF—Type II diabetes mellitus—ADIPOQ—gestational diabetes	0.00064	0.0639	CbGpPWpGaD
Clenbuterol—NGF—SIDS Susceptibility Pathways—GCK—gestational diabetes	0.000445	0.0445	CbGpPWpGaD
Clenbuterol—NGF—MAPK Signaling Pathway—GCK—gestational diabetes	0.00042	0.0419	CbGpPWpGaD
Clenbuterol—TNF—Transcription factor regulation in adipogenesis—LEP—gestational diabetes	0.000398	0.0397	CbGpPWpGaD
Clenbuterol—TNF—Adipogenesis—RETN—gestational diabetes	0.000394	0.0394	CbGpPWpGaD
Clenbuterol—NGF—SIDS Susceptibility Pathways—AR—gestational diabetes	0.000317	0.0316	CbGpPWpGaD
Clenbuterol—NGF—PI3K/AKT activation—FGF2—gestational diabetes	0.000245	0.0245	CbGpPWpGaD
Clenbuterol—TNF—Transcriptional regulation of white adipocyte differentiation—ADIPOQ—gestational diabetes	0.000235	0.0235	CbGpPWpGaD
Clenbuterol—TNF—Regulation of toll-like receptor signaling pathway—MBL2—gestational diabetes	0.000198	0.0198	CbGpPWpGaD
Clenbuterol—TNF—Adipogenesis—NAMPT—gestational diabetes	0.000189	0.0189	CbGpPWpGaD
Clenbuterol—CYP1A2—Phase II conjugation—GGCT—gestational diabetes	0.000189	0.0188	CbGpPWpGaD
Clenbuterol—ADRB3—GPCRs, Class A Rhodopsin-like—MTNR1B—gestational diabetes	0.000177	0.0177	CbGpPWpGaD
Clenbuterol—CYP1A1—Biological oxidations—GGCT—gestational diabetes	0.000173	0.0173	CbGpPWpGaD
Clenbuterol—CYP1A1—Tryptophan metabolism—CYP19A1—gestational diabetes	0.000173	0.0173	CbGpPWpGaD
Clenbuterol—TNF—SIDS Susceptibility Pathways—GCK—gestational diabetes	0.000162	0.0162	CbGpPWpGaD
Clenbuterol—TNF—Angiopoietin receptor Tie2-mediated signaling—FGF2—gestational diabetes	0.000157	0.0156	CbGpPWpGaD
Clenbuterol—TNF—Adipogenesis—ADIPOQ—gestational diabetes	0.000155	0.0154	CbGpPWpGaD
Clenbuterol—TNF—MAPK Signaling Pathway—GCK—gestational diabetes	0.000153	0.0153	CbGpPWpGaD
Clenbuterol—ADRB3—Class A/1 (Rhodopsin-like receptors)—MTNR1B—gestational diabetes	0.000152	0.0152	CbGpPWpGaD
Clenbuterol—TNF—Transcriptional regulation of white adipocyte differentiation—LEP—gestational diabetes	0.000146	0.0146	CbGpPWpGaD
Clenbuterol—TNF—Cardiac Hypertrophic Response—FGF2—gestational diabetes	0.000145	0.0145	CbGpPWpGaD
Clenbuterol—CYP1A1—Cytochrome P450 - arranged by substrate type—CYP19A1—gestational diabetes	0.00014	0.014	CbGpPWpGaD
Clenbuterol—NGF—NGF signalling via TRKA from the plasma membrane—FGF2—gestational diabetes	0.000139	0.0138	CbGpPWpGaD
Clenbuterol—CYP1A1—Oxidation by Cytochrome P450—CYP19A1—gestational diabetes	0.000138	0.0138	CbGpPWpGaD
Clenbuterol—ADRB3—GPCR ligand binding—MTNR1B—gestational diabetes	0.000116	0.0116	CbGpPWpGaD
Clenbuterol—TNF—SIDS Susceptibility Pathways—AR—gestational diabetes	0.000115	0.0115	CbGpPWpGaD
Clenbuterol—CYP1A1—Phase 1 - Functionalization of compounds—CYP19A1—gestational diabetes	0.000113	0.0113	CbGpPWpGaD
Clenbuterol—CYP1A2—Biological oxidations—GGCT—gestational diabetes	0.00011	0.011	CbGpPWpGaD
Clenbuterol—CYP1A2—Tryptophan metabolism—CYP19A1—gestational diabetes	0.00011	0.011	CbGpPWpGaD
Clenbuterol—NGF—Signaling by NGF—FGF2—gestational diabetes	0.000107	0.0106	CbGpPWpGaD
Clenbuterol—NGF—SIDS Susceptibility Pathways—TNF—gestational diabetes	0.000105	0.0105	CbGpPWpGaD
Clenbuterol—ADRB1—GPCRs, Class A Rhodopsin-like—MTNR1B—gestational diabetes	0.000105	0.0105	CbGpPWpGaD
Clenbuterol—TNF—Spinal Cord Injury—LEP—gestational diabetes	0.000104	0.0104	CbGpPWpGaD
Clenbuterol—TNF—MicroRNAs in cardiomyocyte hypertrophy—FGF2—gestational diabetes	0.000103	0.0103	CbGpPWpGaD
Clenbuterol—ADRB2—GPCRs, Class A Rhodopsin-like—MTNR1B—gestational diabetes	0.000103	0.0103	CbGpPWpGaD
Clenbuterol—NGF—MAPK Signaling Pathway—TNF—gestational diabetes	9.93e-05	0.00992	CbGpPWpGaD
Clenbuterol—TNF—Integrated Pancreatic Cancer Pathway—AR—gestational diabetes	9.81e-05	0.00979	CbGpPWpGaD
Clenbuterol—TNF—Adipogenesis—LEP—gestational diabetes	9.6e-05	0.00958	CbGpPWpGaD
Clenbuterol—ADRB1—Class A/1 (Rhodopsin-like receptors)—MTNR1B—gestational diabetes	9.02e-05	0.00901	CbGpPWpGaD
Clenbuterol—CYP1A2—Cytochrome P450 - arranged by substrate type—CYP19A1—gestational diabetes	8.91e-05	0.0089	CbGpPWpGaD
Clenbuterol—ADRB2—Class A/1 (Rhodopsin-like receptors)—MTNR1B—gestational diabetes	8.83e-05	0.00881	CbGpPWpGaD
Clenbuterol—CYP1A2—Oxidation by Cytochrome P450—CYP19A1—gestational diabetes	8.8e-05	0.00878	CbGpPWpGaD
Clenbuterol—NGF—Signaling Pathways—LEPR—gestational diabetes	8.58e-05	0.00857	CbGpPWpGaD
Clenbuterol—CYP1A2—Phase 1 - Functionalization of compounds—CYP19A1—gestational diabetes	7.23e-05	0.00721	CbGpPWpGaD
Clenbuterol—ADRB1—GPCR ligand binding—MTNR1B—gestational diabetes	6.87e-05	0.00686	CbGpPWpGaD
Clenbuterol—NGF—Signaling Pathways—MTNR1B—gestational diabetes	6.78e-05	0.00677	CbGpPWpGaD
Clenbuterol—ADRB2—GPCR ligand binding—MTNR1B—gestational diabetes	6.72e-05	0.00671	CbGpPWpGaD
Clenbuterol—NGF—Signaling Pathways—RBP4—gestational diabetes	6.61e-05	0.0066	CbGpPWpGaD
Clenbuterol—ADRB3—GPCR downstream signaling—MTNR1B—gestational diabetes	6.54e-05	0.00653	CbGpPWpGaD
Clenbuterol—TNF—Developmental Biology—GCK—gestational diabetes	6.45e-05	0.00644	CbGpPWpGaD
Clenbuterol—CYP1A1—Biological oxidations—CYP19A1—gestational diabetes	6.02e-05	0.00601	CbGpPWpGaD
Clenbuterol—ADRB3—Signaling by GPCR—MTNR1B—gestational diabetes	5.94e-05	0.00593	CbGpPWpGaD
Clenbuterol—CYP1A1—Metapathway biotransformation—CYP19A1—gestational diabetes	5.94e-05	0.00593	CbGpPWpGaD
Clenbuterol—CYP1A1—Aryl Hydrocarbon Receptor Pathway—TNF—gestational diabetes	5.6e-05	0.00559	CbGpPWpGaD
Clenbuterol—CYP1A1—Aryl Hydrocarbon Receptor—TNF—gestational diabetes	5.6e-05	0.00559	CbGpPWpGaD
Clenbuterol—TNF—Integrated Pancreatic Cancer Pathway—FGF2—gestational diabetes	5.36e-05	0.00535	CbGpPWpGaD
Clenbuterol—TNF—Developmental Biology—ADIPOQ—gestational diabetes	5.31e-05	0.0053	CbGpPWpGaD
Clenbuterol—ADRB3—Signaling Pathways—LEPR—gestational diabetes	4.44e-05	0.00443	CbGpPWpGaD
Clenbuterol—ADRB1—GPCR downstream signaling—MTNR1B—gestational diabetes	3.88e-05	0.00388	CbGpPWpGaD
Clenbuterol—CYP1A2—Biological oxidations—CYP19A1—gestational diabetes	3.84e-05	0.00383	CbGpPWpGaD
Clenbuterol—ADRB2—GPCR downstream signaling—MTNR1B—gestational diabetes	3.8e-05	0.00379	CbGpPWpGaD
Clenbuterol—CYP1A2—Metapathway biotransformation—CYP19A1—gestational diabetes	3.79e-05	0.00378	CbGpPWpGaD
Clenbuterol—CYP1A2—Aryl Hydrocarbon Receptor—TNF—gestational diabetes	3.57e-05	0.00356	CbGpPWpGaD
Clenbuterol—CYP1A2—Aryl Hydrocarbon Receptor Pathway—TNF—gestational diabetes	3.57e-05	0.00356	CbGpPWpGaD
Clenbuterol—ADRB1—Signaling by GPCR—MTNR1B—gestational diabetes	3.53e-05	0.00352	CbGpPWpGaD
Clenbuterol—ADRB3—Signaling Pathways—MTNR1B—gestational diabetes	3.51e-05	0.0035	CbGpPWpGaD
Clenbuterol—ADRB2—Signaling by GPCR—MTNR1B—gestational diabetes	3.45e-05	0.00344	CbGpPWpGaD
Clenbuterol—ADRB3—Signaling Pathways—RBP4—gestational diabetes	3.42e-05	0.00341	CbGpPWpGaD
Clenbuterol—TNF—Developmental Biology—LEP—gestational diabetes	3.3e-05	0.00329	CbGpPWpGaD
Clenbuterol—NGF—Signaling Pathways—LEP—gestational diabetes	3.01e-05	0.00301	CbGpPWpGaD
Clenbuterol—CYP1A1—Metabolism—GGCT—gestational diabetes	2.96e-05	0.00295	CbGpPWpGaD
Clenbuterol—ADRB1—Signaling Pathways—LEPR—gestational diabetes	2.63e-05	0.00263	CbGpPWpGaD
Clenbuterol—CYP1A1—Metabolism—GLS2—gestational diabetes	2.59e-05	0.00258	CbGpPWpGaD
Clenbuterol—ADRB2—Signaling Pathways—LEPR—gestational diabetes	2.58e-05	0.00257	CbGpPWpGaD
Clenbuterol—TNF—Developmental Biology—FGF2—gestational diabetes	2.51e-05	0.0025	CbGpPWpGaD
Clenbuterol—CYP1A1—Metabolism of lipids and lipoproteins—CYP19A1—gestational diabetes	2.31e-05	0.00231	CbGpPWpGaD
Clenbuterol—NGF—Signaling Pathways—FGF2—gestational diabetes	2.29e-05	0.00229	CbGpPWpGaD
Clenbuterol—ADRB1—Signaling Pathways—MTNR1B—gestational diabetes	2.08e-05	0.00208	CbGpPWpGaD
Clenbuterol—ADRB2—Signaling Pathways—MTNR1B—gestational diabetes	2.04e-05	0.00203	CbGpPWpGaD
Clenbuterol—ADRB1—Signaling Pathways—RBP4—gestational diabetes	2.03e-05	0.00203	CbGpPWpGaD
Clenbuterol—ADRB2—Signaling Pathways—RBP4—gestational diabetes	1.99e-05	0.00198	CbGpPWpGaD
Clenbuterol—CYP1A2—Metabolism—GGCT—gestational diabetes	1.89e-05	0.00188	CbGpPWpGaD
Clenbuterol—CYP1A2—Metabolism—GLS2—gestational diabetes	1.65e-05	0.00165	CbGpPWpGaD
Clenbuterol—ADRB3—Signaling Pathways—LEP—gestational diabetes	1.56e-05	0.00156	CbGpPWpGaD
Clenbuterol—CYP1A2—Metabolism of lipids and lipoproteins—CYP19A1—gestational diabetes	1.47e-05	0.00147	CbGpPWpGaD
Clenbuterol—CYP1A1—Metabolism—NAMPT—gestational diabetes	1.42e-05	0.00141	CbGpPWpGaD
Clenbuterol—CYP1A1—Metabolism—GCK—gestational diabetes	1.41e-05	0.00141	CbGpPWpGaD
Clenbuterol—ADRB3—Signaling Pathways—FGF2—gestational diabetes	1.18e-05	0.00118	CbGpPWpGaD
Clenbuterol—CYP1A1—Metabolism—CYP19A1—gestational diabetes	1.03e-05	0.00103	CbGpPWpGaD
Clenbuterol—ADRB1—Signaling Pathways—LEP—gestational diabetes	9.25e-06	0.000924	CbGpPWpGaD
Clenbuterol—ADRB2—Signaling Pathways—LEP—gestational diabetes	9.05e-06	0.000904	CbGpPWpGaD
Clenbuterol—CYP1A2—Metabolism—NAMPT—gestational diabetes	9.04e-06	0.000902	CbGpPWpGaD
Clenbuterol—CYP1A2—Metabolism—GCK—gestational diabetes	8.98e-06	0.000896	CbGpPWpGaD
Clenbuterol—ADRB1—Signaling Pathways—FGF2—gestational diabetes	7.03e-06	0.000702	CbGpPWpGaD
Clenbuterol—ADRB2—Signaling Pathways—FGF2—gestational diabetes	6.88e-06	0.000686	CbGpPWpGaD
Clenbuterol—CYP1A2—Metabolism—CYP19A1—gestational diabetes	6.57e-06	0.000655	CbGpPWpGaD
